848 related articles for article (PubMed ID: 22025288)
1. Cellular senescence and tumor suppressor gene p16.
Rayess H; Wang MB; Srivatsan ES
Int J Cancer; 2012 Apr; 130(8):1715-25. PubMed ID: 22025288
[TBL] [Abstract][Full Text] [Related]
2. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the INK4a/Arf gene locus in senescence.
Collins CJ; Sedivy JM
Aging Cell; 2003 Jun; 2(3):145-50. PubMed ID: 12882406
[TBL] [Abstract][Full Text] [Related]
4. Replicative senescence revisited.
Marcotte R; Wang E
J Gerontol A Biol Sci Med Sci; 2002 Jul; 57(7):B257-69. PubMed ID: 12084796
[TBL] [Abstract][Full Text] [Related]
5. Conjugated Physiological Resveratrol Metabolites Induce Senescence in Breast Cancer Cells: Role of p53/p21 and p16/Rb Pathways, and ABC Transporters.
Giménez-Bastida JA; Ávila-Gálvez MÁ; Espín JC; González-Sarrías A
Mol Nutr Food Res; 2019 Nov; 63(22):e1900629. PubMed ID: 31441212
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressors and oncogenes in cellular senescence.
Bringold F; Serrano M
Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053
[TBL] [Abstract][Full Text] [Related]
7. An RNA interference screen for identifying downstream effectors of the p53 and pRB tumour suppressor pathways involved in senescence.
Rovillain E; Mansfield L; Lord CJ; Ashworth A; Jat PS
BMC Genomics; 2011 Jul; 12():355. PubMed ID: 21740549
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of cellular senescence in human and mouse cells.
Itahana K; Campisi J; Dimri GP
Biogerontology; 2004; 5(1):1-10. PubMed ID: 15138376
[TBL] [Abstract][Full Text] [Related]
9. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
[TBL] [Abstract][Full Text] [Related]
10. Exploiting pivotal mechanisms behind the senescence-like cell cycle arrest in cancer.
Zarneshan SN; Fakhri S; Bachtel G; Bishayee A
Adv Protein Chem Struct Biol; 2023; 135():1-19. PubMed ID: 37061329
[TBL] [Abstract][Full Text] [Related]
11. PR55α-controlled protein phosphatase 2A inhibits p16 expression and blocks cellular senescence induction by γ-irradiation.
Palanivel C; Madduri LSV; Hein AL; Jenkins CB; Graff BT; Camero AL; Zhou S; Enke CA; Ouellette MM; Yan Y
Aging (Albany NY); 2024 Mar; 16(5):4116-4137. PubMed ID: 38441530
[TBL] [Abstract][Full Text] [Related]
12. p16(INK4a) and the control of cellular proliferative life span.
Huschtscha LI; Reddel RR
Carcinogenesis; 1999 Jun; 20(6):921-6. PubMed ID: 10357768
[TBL] [Abstract][Full Text] [Related]
13. CREG1 enhances p16(INK4a) -induced cellular senescence.
Moolmuang B; Tainsky MA
Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
[TBL] [Abstract][Full Text] [Related]
14. Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging.
Zhang H
J Cell Physiol; 2007 Mar; 210(3):567-74. PubMed ID: 17133363
[TBL] [Abstract][Full Text] [Related]
15. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
[TBL] [Abstract][Full Text] [Related]
16. [Cyclin dependent kinase inhibitors and replicative senescence].
Gerland LM; Ffrench M; Magaud JP
Pathol Biol (Paris); 2001 Dec; 49(10):830-9. PubMed ID: 11776695
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest.
Sheahan S; Bellamy CO; Dunbar DR; Harrison DJ; Prost S
BMC Cancer; 2007 Nov; 7():215. PubMed ID: 18021445
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling.
Chen L; Yang R; Qiao W; Zhang W; Chen J; Mao L; Goltzman D; Miao D
Aging Cell; 2019 Jun; 18(3):e12951. PubMed ID: 30907059
[TBL] [Abstract][Full Text] [Related]
19. The signals and pathways activating cellular senescence.
Ben-Porath I; Weinberg RA
Int J Biochem Cell Biol; 2005 May; 37(5):961-76. PubMed ID: 15743671
[TBL] [Abstract][Full Text] [Related]
20. Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts.
Wei W; Herbig U; Wei S; Dutriaux A; Sedivy JM
EMBO Rep; 2003 Nov; 4(11):1061-6. PubMed ID: 14566323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
